- Home
- SVRA vs PMT Comparison
SVRA vs PMT Comparison
Compare SVRA & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | PMT |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | SVRA | PMT |
|---|---|---|
| Price | $5.60 | $12.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $7.33 | ★ $13.67 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 03-26-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 12.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | N/A | ★ $721,170,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.09 |
| P/E Ratio | ★ N/A | $12.78 |
| Revenue Growth | N/A | ★ 42.92 |
| 52 Week Low | $1.89 | $11.60 |
| 52 Week High | $7.01 | $14.93 |
Technical Indicators
Market Signals| Indicator | SVRA | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 49.61 |
| Support Level | $5.10 | $11.88 |
| Resistance Level | $5.44 | $12.46 |
| Average True Range (ATR) | 0.35 | 0.40 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 52.33 | 48.71 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.